$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

HIV 유전자 치료를 위한 anti-HIV RNA와 바이러스 벡터 연구 동향
Anti-HIV RNAs and Viral Vectors for Gene Therapy 원문보기

생명과학회지 = Journal of life science, v.18 no.5 = no.97, 2008년, pp.738 - 746  

박정혜 (플로리다 대학교 수의과대학 전염성 질환 및 병리학과)

초록
AI-Helper 아이콘AI-Helper

Human immunodeficiency virus(HIV)의 발견이후 다양한 AIDS 치료요법이 지속적으로 개발되어 왔다. HIV 바이러스의 복제를 억제하기 위하여, 바이러스 단백질 기능을 억제하는 기존의 약물 뿐 아니라 RNA decoy, anti-sense RNA, ribozyme 등의 RNA 기법이 근래에 활발히 연구되어 왔다. 특히, 최근에는 small interfering RNA(siRNA)를 이용하여 HIV 바이러스를 억제하는 연구가 기존의 RNA 기법과 더불어 새로이 연구되고 있다. 이러한 anti-HIV RNA들은 작은 분자물질이고 쉽게 조작이 가능 하며 바이러스 억제에도 아주 효과적인 이점이 있으나, 장기적이고도 안정적으로 발현하기 위해서는 세포내로 전달하는 수단과 해당세포에 독성을 일으키지 않도록 적당량 발현하기 위한 유전자 발현체계 등은 신중히 선택하여야 할 사항이다. HIV는 유전자 돌연 변이율이 높은 까닭에 HIV 치료제에도 생존하는 유전자 변이 바이러스가 자주 발견된다. 그러므로 효과적인 HIV 치료를 위해서는 HIV RNA의 여러 부위를 표적으로 여러 종류의 HIV 억제제들을 복합적으로 사용하여야 하며 이를 위해서는 다양한 유형의 anti-HIV RNA가 개발되어야 한다. HIV의 복제를 억제하기 위한 치료용 RNA를 개발하기 위한 연구의 일환으로서 HIV RNA에 대한 표적부위의 선택, 여러 가지 치료용 RNA의 종류와 그 RNA의 발현방법, 그리고 치료용 RNA를 세포 내에 전달하는 수단으로 사용되는 바이러스 벡터 등에 관한 최근의 연구 동향을 집중적으로 알아 보고자 한다.

Abstract AI-Helper 아이콘AI-Helper

Human immunodeficiency virus (HIV) therapy has been in continuous development since the discovery of HIV. Various RNA genes to inhibit HIV replication have been deployed such as RNA decoy, antisense RNA, ribozyme, as well as conventional drugs that inhibit viral proteins. Small interfering RNAs (siR...

주제어

참고문헌 (84)

  1. Ambros, Victor. The functions of animal microRNAs. Nature, vol.431, no.7006, 350-355.

  2. An, Dong Sung, Donahue, Robert E., Kamata, Masakazu, Poon, Betty, Metzger, Mark, Mao, Si-Hua, Bonifacino, Aylin, Krouse, Allen E., Darlix, Jean-Luc, Baltimore, David, Qin, F. Xiao-Feng, Chen, Irvin S. Y.. Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates. Proceedings of the National Academy of Sciences of the United States of America, vol.104, no.32, 13110-13115.

  3. An, Dong Sung, Qin, F. Xiao-Feng, Auyeung, Vincent C., Mao, Si Hua, Kung, Sam K.P., Baltimore, David, Chen, Irvin S.Y.. Optimization and Functional Effects of Stable Short Hairpin RNA Expression in Primary Human Lymphocytes via Lentiviral Vectors. Molecular therapy : the journal of the American Society of Gene Therapy, vol.14, no.4, 494-504.

  4. Anderson, Joseph, Akkina, Ramesh. CXCR4 and CCR5 shRNA transgenic CD34+ cell derived macrophages are functionally normal and resist HIV-1 infection. Retrovirology, vol.2, 53-53.

  5. Balog, Katalin, Minarovits, J.. NEF: A Pleiotropic Modulator of Primate Lentivirus Infectivity and Pathogenesis. Acta microbiologica et immunologica Hungarica, vol.53, no.1, 51-75.

  6. Barichievy, Samantha, Saayman, Sheena, von Eije, Karin J., Morris, Kevin V., Arbuthnot, Patrick, Weinberg, Marc S.. The Inhibitory Efficacy of RNA POL III-Expressed Long Hairpin RNAs Targeted to Untranslated Regions of the HIV-1 5′ Long Terminal Repeat. Oligonucleotides, vol.17, no.4, 419-432.

  7. Barnor, Jacob Samson, Miyano-Kurosaki, Naoko, Yamaguchi, Kazuya, Abumi, Yusuke, Ishikawa, Koichi, Yamamoto, Naoki, Takaku, Hiroshi. Lentiviral-Mediated Delivery of Combined HIV-1 Decoy TAR and Vif siRNA as a Single 1RNA Molecule that Cleaves to Inhibit HIV-1 in Transduced Cells. Nucleosides, nucleotides & nucleic acids, vol.24, no.5, 431-434.

  8. 10.4161/rna.2.2.2044 

  9. Bartel, David P. MicroRNAs : Genomics, Biogenesis, Mechanism, and Function. Cell, vol.116, no.2, 281-297.

  10. Beard, Brian C., Keyser, Kirsten A., Trobridge, Grant D., Peterson, Laura J., Miller, Daniel G., Jacobs, Michael, Kaul, Rajinder, Kiem, Hans-Peter. Unique Integration Profiles in a Canine Model of Long-Term Repopulating Cells Transduced with Gammaretrovirus, Lentivirus, or Foamy Virus. Human gene therapy, vol.18, no.5, 423-434.

  11. Bernstein, Emily, Caudy, Amy A., Hammond, Scott M., Hannon, Gregory J.. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature, vol.409, no.6818, 363-366.

  12. Blankson, Joel N., Persaud, Deborah, Siliciano, Robert F.. THE CHALLENGE OF VIRAL RESERVOIRS IN HIV-1 INFECTION. Annual review of medicine, vol.53, 557-593.

  13. 10.1128/JVI.77.21.11531-11535.2003 

  14. Boden, Daniel, Pusch, Oliver, Silbermann, Rebecca, Lee, Fred, Tucker, Lynne, Ramratnam, Bharat. Enhanced gene silencing of HIV‐1 specific siRNA using microRNA designed hairpins. Nucleic acids research, vol.32, no.3, 1154-1158.

  15. Boneva, Roumiana S., Switzer, William M., Spira, Thomas J., Bhullar, Vinod B., Shanmugam, Vedapuri, Cong, Mian-Er, Lam, Lee, Heneine, Walid, Folks, Thomas M., Chapman, Louisa E.. Clinical and Virological Characterization of Persistent Human Infection with Simian Foamy Viruses. AIDS research and human retroviruses, vol.23, no.11, 1330-1337.

  16. Carmell, Michelle A., Zhang, Liqun, Conklin, Douglas S., Hannon, Gregory J., Rosenquist, Thomas A.. Germline transmission of RNAi in mice. Nature structural biology, vol.10, no.2, 91-92.

  17. Castanotto, Daniela, Sakurai, Kumi, Lingeman, Robert, Li, Haitang, Shively, Louise, Aagaard, Lars, Soifer, Harris, Gatignol, Anne, Riggs, Arthur, Rossi, John J.. Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC. Nucleic acids research, vol.35, no.15, 5154-5164.

  18. Caudy, Amy A., Myers, Mike, Hannon, Gregory J., Hammond, Scott M.. Fragile X-related protein and VIG associate with the RNA interference machinery. Genes & development, vol.16, no.19, 2491-2496.

  19. Cave, Eleanor, Weinberg, Marc S., Cilliers, Tonie, Carmona, Sergio, Morris, Lynn, Arbuthnot, Patrick. Silencing of HIV-1 Subtype C Primary Isolates by Expressed Small Hairpin RNAs Targeted togag. AIDS research and human retroviruses, vol.22, no.5, 401-410.

  20. Chang, L-J, Liu, X, He, J. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1. Gene therapy, vol.12, no.14, 1133-1144.

  21. 10.1128/JVI.76.18.9225-9231.2002 

  22. 10.1128/JVI.78.5.2601-2605.2004 

  23. Dean, Michael, Carrington, Mary, Winkler, Cheryl, Huttley, Gavin A., Smith, Michael W., Allikmets, Rando, Goedert, James J., Buchbinder, Susan P., Vittinghoff, Eric, Gomperts, Edward, Donfield, Sharyne, Vlahov, David, Kaslow, Richard, Saah, Alfred, Rinaldo, Charles, Detels, Roger, O'Brien, Stephen J.. Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene. Science, vol.273, no.5283, 1856-1862.

  24. 10.1038/sj.gt.3300780 

  25. Gao, Yong, Lobritz, Michael A., Roth, Justin, Abreha, Measho, Nelson, Kenneth N., Nankya, Immaculate, Moore-Dudley, Dawn M., Abraha, Awet, Gerson, Stanton L., Arts, Eric J.. Targets of Small Interfering RNA Restriction during Human Immunodeficiency Virus Type 1 Replication. Journal of virology, vol.82, no.6, 2938-2951.

  26. Grimm, Dirk, Streetz, Konrad L., Jopling, Catherine L., Storm, Theresa A., Pandey, Kusum, Davis, Corrine R., Marion, Patricia, Salazar, Felix, Kay, Mark A.. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature, vol.441, no.7092, 537-541.

  27. Gu, Shuo, Ji, Jianfei, Kim, James D., Yee, Jiing-Kuan, Rossi, John J.. Inhibition of Infectious Human Immunodeficiency Virus Type 1 Virions via Lentiviral Vector Encoded Short Antisense RNAs. Oligonucleotides, vol.16, no.4, 287-295.

  28. Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., Sorensen, R., Forster, A., Fraser, P., Cohen, J. I., de Saint Basile, G., Alexander, I., Wintergerst, U., Frebourg, T., Aurias, A., Stoppa-Lyonnet, D., Romana, S., Radford-Weiss, I., Gross, F., Valensi, F., Delabesse, E., Macintyre, E., Sigaux, F., Soulier, J., Leiva, L. E., Wissler, M., Prinz, C., Rabbitts, T. H., Le Deist, F., Fischer, A., Cavazzana-Calvo, M.. LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1. Science, vol.302, no.5644, 415-419.

  29. Hacker, Caroline V., Vink, Conrad A., Wardell, Theresa W., Lee, Sheena, Treasure, Peter, Kingsman, Susan M., Mitrophanous, Kyriacos A., Miskin, James E.. The integration profile of EIAV-based vectors. Molecular therapy : the journal of the American Society of Gene Therapy, vol.14, no.4, 536-545.

  30. Hammond, Scott M., Bernstein, Emily, Beach, David, Hannon, Gregory J.. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature, vol.404, no.6775, 293-296.

  31. Hayafune, Masaaki, Miyano-Kurosaki, Naoko, Takaku, Hiroshi, Park, Wee-Sung. Silencing of HIV-1 Gene Expression by Sirnas in Transduced Cells. Nucleosides, nucleotides & nucleic acids, vol.25, no.7, 795-799.

  32. Ikeda, T., Shibata, J., Yoshimura, K., Koito, A., Matsushita, S.. Recurrent HIV-1 Integration at the BACH2 Locus in Resting CD4+ T Cell Populations during Effective Highly Active Antiretroviral Therapy. The Journal of infectious diseases : official publication of the Infectious Diseases Society of America, vol.195, no.5, 716-725.

  33. 10.4161/rna.2.3.2045 

  34. Jacque, Jean-Marc, Triques, Karine, Stevenson, Mario. Modulation of HIV-1 replication by RNA interference. Nature, vol.418, no.6896, 435-438.

  35. Konstantinova, P, de Vries, W, Haasnoot, J, ter Brake, O, de Haan, P, Berkhout, B. Inhibition of human immunodeficiency virus type 1 by RNA interference using long-hairpin RNA. Gene therapy, vol.13, no.19, 1403-1413.

  36. Lai, Eric C.. Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation. Nature genetics, vol.30, no.4, 363-364.

  37. Lassen, Kara, Han, Yefei, Zhou, Yan, Siliciano, Janet, Siliciano, Robert F.. The multifactorial nature of HIV-1 latency. Trends in molecular medicine, vol.10, no.11, 525-531.

  38. Laufs, Stephanie, Guenechea, Guillermo, Gonzalez-Murillo, Africa, Zsuzsanna Nagy, K., Luz Lozano, M., del Val, Coral, Jonnakuty, Sunitha, Hotz-Wagenblatt, Agnes, Jens Zeller, W., Bueren, Juan A., Fruehauf, Stefan. Lentiviral vector integration sites in human NOD/SCID repopulating cells. The journal of gene medicine, vol.8, no.10, 1197-1207.

  39. Lee, Yoontae, Ahn, Chiyoung, Han, Jinju, Choi, Hyounjeong, Kim, Jaekwang, Yim, Jeongbin, Lee, Junho, Provost, Patrick, Rådmark, Olof, Kim, Sunyoung, Kim, V. Narry. The nuclear RNase III Drosha initiates microRNA processing. Nature, vol.425, no.6956, 415-419.

  40. Lehrman, Ginger, Hogue, Ian B, Palmer, Sarah, Jennings, Cheryl, Spina, Celsa A, Wiegand, Ann, Landay, Alan L, Coombs, Robert W, Richman, Douglas D, Mellors, John W, Coffin, John M, Bosch, Ronald J, Margolis, David M. Depletion of latent HIV-1 infection in vivo: a proof-of-concept study. The Lancet, vol.366, no.9485, 549-555.

  41. Leonard, J N, Schaffer, D V. Antiviral RNAi therapy: emerging approaches for hitting a moving target. Gene therapy, vol.13, no.6, 532-540.

  42. LI, MINGJIE, LI, HAITANG, ROSSI, JOHN J.. RNAi in Combination with a Ribozyme and TAR Decoy for Treatment of HIV Infection in Hematopoietic Cell Gene Therapy. Annals of the New York Academy of Sciences, vol.1082, no.1, 172-179.

  43. Li, Ming-Jie, Bauer, Gerhard, Michienzi, Alessandro, Yee, Jiing-Kuan, Lee, Nan-Sook, Kim, James, Li, Shirley, Castanotto, Daniela, Zaia, John, Rossi, John J. Inhibition of HIV-1 infection by lentiviral vectors expressing pol III-promoted anti-HIV RNAs. Molecular therapy : the journal of the American Society of Gene Therapy, vol.8, no.2, 196-206.

  44. Li, Ming-Jie, Kim, James, Li, Shirley, Zaia, John, Yee, Jiing-Kuan, Anderson, Joseph, Akkina, Ramesh, Rossi, John J.. Long-Term Inhibition of HIV-1 Infection in Primary Hematopoietic Cells by Lentiviral Vector Delivery of a Triple Combination of Anti-HIV shRNA, Anti-CCR5 Ribozyme, and a Nucleolar-Localizing TAR Decoy. Molecular therapy : the journal of the American Society of Gene Therapy, vol.12, no.5, 900-909.

  45. Linial, Maxine. Why aren’t foamy viruses pathogenic?. Trends in microbiology, vol.8, no.6, 284-289.

  46. Liu, Xiang, Jiang, Feng, Kalidas, Savitha, Smith, Dean, Liu, Qinghua. Dicer-2 and R2D2 coordinately bind siRNA to promote assembly of the siRISC complexes. RNA, vol.12, no.8, 1514-1520.

  47. Lo, H-L, Chang, T, Yam, P, Marcovecchio, P M, Li, S, Zaia, J A, Yee, J-K. Inhibition of HIV-1 replication with designed miRNAs expressed from RNA polymerase II promoters. Gene therapy, vol.14, no.21, 1503-1512.

  48. Lu, Xiaobin, Yu, Qiao, Binder, Gwendolyn K., Chen, Ziping, Slepushkina, Tatiana, Rossi, John, Dropulic, Boro. Antisense-Mediated Inhibition of Human Immunodeficiency Virus (HIV) Replication by Use of an HIV Type 1-Based Vector Results in Severely Attenuated Mutants Incapable of Developing Resistance. Journal of virology, vol.78, no.13, 7079-7088.

  49. Lund, Elsebet, Güttinger, Stephan, Calado, Angelo, Dahlberg, James E., Kutay, Ulrike. Nuclear Export of MicroRNA Precursors. Science, vol.303, no.5654, 95-98.

  50. Mautino, Mario R., Morgan, Richard A.. Enhanced Inhibition of Human Immunodeficiency Virus Type 1 Replication by Novel Lentiviral Vectors Expressing Human Immunodeficiency Virus Type 1 Envelope Antisense RNA. Human gene therapy, vol.13, no.9, 1027-1037.

  51. Medin, Jeffrey A., Karlsson, Stefan. Viral vectors for gene therapy of hematopoietic cells. Immunotechnology, vol.3, no.1, 3-19.

  52. Mergia, Ayalew, Chari, Soumya, Kolson, Dennis L., Goodenow, Maureen M., Ciccarone, Tina. The Efficiency of Simian Foamy Virus Vector Type-1 (SFV-1) in Nondividing Cells and in Human PBLs. Virology, vol.280, no.2, 243-252.

  53. Mergia, A., Luciw, P.A.. Replication and regulation of primate foamy viruses. Virology, vol.184, no.2, 475-482.

  54. Miyagishi, M, Taira, K. U6 promoter–driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nature biotechnology, vol.20, no.5, 497-500.

  55. 10.4161/rna.2.1.1198 

  56. Myslinski, Evelyne, Amé, Jean-Christophe, Krol, Alain, Carbon, Philippe. An unusually compact external promoter for RNA polymerase III transcription of the human H1RNA gene. Nucleic acids research, vol.29, no.12, 2502-2509.

  57. 10.1099/vir.0.81554-0 

  58. Park, Jeonghae, Nadeau, Peter, Zucali, James R., Johnson, Calvin M., Mergia, Ayalew. Inhibition of simian immunodeficiency virus by foamy virus vectors expressing siRNAs. Virology, vol.343, no.2, 275-282.

  59. Park, W-S, Hayafune, M, Miyano-Kurosaki, N, Takaku, H. Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells. Gene therapy, vol.10, no.24, 2046-2050.

  60. Peng, Y., Lu, J.X., Shen, X.F.. shRNA driven by Pol II/T7 dual-promoter system effectively induce cell-specific RNA interference in mammalian cells. Biochemical and biophysical research communications, vol.360, no.2, 496-500.

  61. Rao, Manjeet K, Wilkinson, Miles F. Tissue-specific and cell type–specific RNA interference in vivo. Nature protocols, vol.1, no.3, 1494-1501.

  62. Rivas, Fabiola V, Tolia, Niraj H, Song, Ji-Joon, Aragon, Juan P, Liu, Jidong, Hannon, Gregory J, Joshua-Tor, Leemor. Purified Argonaute2 and an siRNA form recombinant human RISC. Nature structural & molecular biology, vol.12, no.4, 340-349.

  63. 10.2144/05384RN01 

  64. Rossi, John J, June, Carl H, Kohn, Donald B. Genetic therapies against HIV. Nature biotechnology, vol.25, no.12, 1444-1454.

  65. Samson, M., Labbe, O., Mollereau, C., Vassart, G., Parmentier, M.. Molecular Cloning and Functional Expression of a New Human CC-Chemokine Receptor Gene. Biochemistry, vol.35, no.11, 3362-3367.

  66. 10.1038/sj.mt.6300298 

  67. 10.4161/cc.6.4.3807 

  68. Schröder, Astrid R.W., Shinn, Paul, Chen, Huaming, Berry, Charles, Ecker, Joseph R., Bushman, Frederic. HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots. Cell, vol.110, no.4, 521-529.

  69. Sui, Guangchao, Soohoo, Christina, Affar, El Bachir, Gay, Frédérique, Shi, Yujiang, Forrester, William C., Shi, Yang. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America, vol.99, no.8, 5515-5520.

  70. Taylor, Jason A, Vojtech, Lucia, Bahner, Ingrid, Kohn, Donald B, Laer, Dorothee Von, Russell, David W, Richard, Robert E. Foamy Virus Vectors Expressing Anti-HIV Transgenes Efficiently Block HIV-1 Replication. Molecular therapy : the journal of the American Society of Gene Therapy, vol.16, no.1, 46-51.

  71. ter Brake, Olivier, Konstantinova, Pavlina, Ceylan, Mustafa, Berkhout, Ben. Silencing of HIV-1 with RNA Interference: a Multiple shRNA Approach. Molecular therapy : the journal of the American Society of Gene Therapy, vol.14, no.6, 883-892.

  72. Trobridge, Grant D., Miller, Daniel G., Jacobs, Michael A., Allen, James M., Kiem, Hans-Peter, Kaul, Rajinder, Russell, David W.. Foamy virus vector integration sites in normal human cells. Proceedings of the National Academy of Sciences of the United States of America, vol.103, no.5, 1498-1503.

  73. Unwalla, Hoshang J., Li, Hai-Tang, Bahner, Ingrid, Li, Ming-Jie, Kohn, Donald, Rossi, John J.. Novel Pol II Fusion Promoter Directs Human Immunodeficiency Virus Type 1-Inducible Coexpression of a Short Hairpin RNA and Protein. Journal of virology, vol.80, no.4, 1863-1873.

  74. Unwalla, Hoshang J, Li, Ming-Jie, Kim, James D, Li, Hai Tang, Ehsani, Ali, Alluin, Jessica, Rossi, John J. Negative feedback inhibition of HIV-1 by TAT-inducible expression of siRNA. Nature biotechnology, vol.22, no.12, 1573-1578.

  75. Volpe, Tom, Schramke, Vera, Hamilton, Georgina L., White, Sharon A., Teng, Grace, Martienssen, Robert A., Allshire, Robin C.. RNA interference is required for normal centromere function infission yeast. Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology, vol.11, no.2, 137-146.

  76. Volpe, Thomas A., Kidner, Catherine, Hall, Ira M., Teng, Grace, Grewal, Shiv I. S., Martienssen, Robert A.. Regulation of Heterochromatic Silencing and Histone H3 Lysine-9 Methylation by RNAi. Science, vol.297, no.5588, 1833-1837.

  77. Wassenegger, Michael. The Role of the RNAi Machinery in Heterochromatin Formation. Cell, vol.122, no.1, 13-16.

  78. 10.1186/1742-4690-3-57 

  79. Wu, Xiaolin, Li, Yuan, Crise, Bruce, Burgess, Shawn M.. Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration. Science, vol.300, no.5626, 1749-1751.

  80. Yi, Rui, Qin, Yi, Macara, Ian G., Cullen, Bryan R.. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes & development, vol.17, no.24, 3011-3016.

  81. 10.1261/rna.2780503 

  82. Zeng, Yan, Wagner, Eric J, Cullen, Bryan R. Both Natural and Designed Micro RNAs Can Inhibit the Expression of Cognate mRNAs When Expressed in Human Cells. Molecular cell, vol.9, no.6, 1327-1333.

  83. Zhou, N, Fang, J, Mukhtar, M, Acheampong, E, Pomerantz, R J. Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4. Gene therapy, vol.11, no.23, 1703-1712.

  84. Zucali, James R., Ciccarone, Tina, Kelley, Vicky, Park, Jeonghae, Johnson, Calvin M., Mergia, Ayalew. Transduction of Umbilical Cord Blood CD34+ NOD/SCID-Repopulating Cells by Simian Foamy Virus Type 1 (SFV-1) Vector. Virology, vol.302, no.2, 229-235.

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로